TGFBR2 and colorectal carcinoma: However, some studies have suggested that inactivation of TβRII may induce (along with KRAS mutations) intestinal neoplasms in mice in a β-catenin-independent pathway [119] and enhance the expression of vascular epithelial growth factor-A, thereby increasing the metastatic potential of CRC cells [120].